Through 22-24 March, Chris L. Pashos, Lucy Nelson, Stephen Ralston, Susan Oliveria and Richard Chumbley visited Amsterdam to represent Genesis Research Group at the World EPA Congress 2022, Europe’s largest congress in market access, pricing, and evidence.
As sponsors of this influential event – attended by global pharma, biotech, payers and HTAs – we worked from a custom-designed stand (described by many as the best at the event!), and enjoyed connecting, and reconnecting, with numerous industry colleagues over three days of presentations, round table discussions, and networking.
In addition, on the first day, our Chief Scientific Officer Susan Oliveria was invited to present on the topic of ensuring fit-for-purpose real world data (RWD) to generate real world evidence (RWE).
Susan commented: “Events like this are beneficial because they allow us to interact with our colleagues and stakeholders. Not only do we have an opportunity to learn from them and see what’s going on in our industry, these events also allow us to have individual one-on-one collaborations and discussions.”
Genesis Research Group board member and Chief Medical Officer Chris Pashos added: “Thanks to the organisers for holding such a premier event, giving consultancies like ours the opportunity to meet payers and HTA organisations, as well as biotech and pharma clients and potential clients. It’s really important to meet the people who influence what we focus on, how we focus on it, and what we produce for our partners. Having these discussions on a regular basis is one of the reasons we’re so good at what we do.”
To find out more about our tech-enabled RWE and HEOR research partnerships, contact solutions@grg.inspya.net or visit grg.inspya.net.
